Field guide to next-generation DNA sequencers.

[BadDNA]

E-mail the author ([email protected]) and he will send you a pdf. Updated tables are available at:

http://www.molecularecologist.com/next-gen-fieldguide/

[husamia]

thanks but I can't get a copy of the transcript

update:
found it here

http://onlinelibrary.wiley.com/doi/1...11.03024.x/pdf

[ECO]

Looks like an interesting read that Newsbot missed. Link here: http://www.ncbi.nlm.nih.gov/pubmed/21592312

Field guide to next-generation DNA sequencers.
Glenn TC.
Source
Department of Environmental Health Science and Georgia Genomics Facility, Environmental Health Science Building, University of Georgia, Athens, GA 30602, USA.
Abstract
The diversity of available 2(nd) and 3(rd) generation DNA sequencing platforms is increasing rapidly. Costs for these systems range from <$100 000 to more than $1 000 000, with instrument run times ranging from minutes to weeks. Extensive trade-offs exist among these platforms. I summarize the major characteristics of each commercially available platform to enable direct comparisons. In terms of cost per megabase (Mb) of sequence, the Illumina and SOLiD platforms are clearly superior (≤$0.10/Mb vs. >$10/Mb for 454 and some Ion Torrent chips). In terms of cost per nonmultiplexed sample and instrument run time, the Pacific Biosciences and Ion Torrent platforms excel, with the 454 GS Junior and Illumina MiSeq also notable in this regard. All platforms allow multiplexing of samples, but details of library preparation, experimental design and data analysis can constrain the options. The wide range of characteristics among available platforms provides opportunities both to conduct groundbreaking studies and to waste money on scales that were previously infeasible. Thus, careful thought about the desired characteristics of these systems is warranted before purchasing or using any of them. Updated information from this guide will be maintained at: http://dna.uga.edu/ and http://tomato.biol.trinity.edu/blog/.

© 2011 Blackwell Publishing Ltd.

PMID: 21592312 [PubMed - as supplied by publisher]